4.4 Article

An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism

Journal

VIROLOGY
Volume 324, Issue 1, Pages 103-116

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2004.03.028

Keywords

gene therapy; adenovirus; targeting; tropism modification; coxsackie and adenovirus receptor (CAR)

Categories

Funding

  1. NCI NIH HHS [T32 CA75930, R01 CA86881, R01 CA93796, R01 CA090547, P50 CA89019] Funding Source: Medline
  2. NHLBI NIH HHS [R01 HL67962] Funding Source: Medline
  3. NIA NIH HHS [R01 AG021875] Funding Source: Medline

Ask authors/readers for more resources

Many clinically relevant tissues are refractory to Ad5 transduction because of negligible levels of the primary Ad5 receptor, the coxsackie and adenovirus receptor (CAR). Thus, development of Ad vectors that display CAR-independent tropism could lead directly to therapeutic gain. The Toronto strain of canine adenovirus type 2 (CAV2) exhibits native tropism that is augmented by, but not fully dependent upon, CAR for cellular transduction. We hypothesized that an Ad5 vector containing the nonhuman CAV2 knob would provide expanded tropism and constructed Ad5Luc1-CK, an E1-deleted Ad5 vector encoding the fiber knob domain from CAV2. Ad5Luc1-CK gene delivery to CAR-deficient cells was augmented up to 30-fold versus the Ad5 control vector, and correlated with increased cell surface binding. Further, we confirmed the importance of cellular integrins to Ad5Luc1-CK transduction. Herein, we present the rationale, design, purification, and characterization of a novel tropism modified, infectivity-enhanced Ad vector. (C) 2004 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available